如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Anti-human CD34 Antibody
產(chǎn)品型號:
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關文檔
簡單介紹
Anti-human CD34 Antibody
的詳細介紹
| Overview |
Print Version
|
| Product Name |
Anti-human CD34 Antibody |
| Description |
mAb name/Clone: 43A1
Human CD34 is an unusual glycosylated membrane protein exclusively expressed on immature hematopoietic cells and on endothelial cells. CD34 may have a role in cell adhesion. CD34 has extensive utility for bone marrow transplantation. Antibody 43A1 recognizes a class 2 epitope of the 110 kd CD34 molecule. |
| Subtype |
monoclonal |
| Application |
IP,Flow Cyt,other |
| Raised In |
mouse |
| Specificity |
Antibody 43A1 recognizes a class 2 epitope of the 110 kd CD34 molecule (1, 2). |
| Immunogen |
Human KG-1a tumor cells |
| Guarantee |
abm guarantees that all our Anti-human CD34 Antibody will perform as described on this product webpage, if this is not the case we will provide you with a one-time replacement at no extra cost. Documentation and explanation of experiment conducted will be required when submitting a claim for replacement. |
| Properties |
|
| Formulation |
Liquid |
| Quantity |
100 μl |
| Clone |
Monoclonal |
| Storage |
This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt. |
| Storage Buffer |
PBS, pH 7.4 with 0.02% sodium azide. |
| Concentration |
1μg/ul |
| Purity |
Protein A Purified |
| Isotype |
IgG3 kappa |
| Species Reactivity |
human |
| Specific References |
|
Y077039 has been referenced in 1 publication.
-
1. H.J. B??hring, et al, (1991) Leukemia 5: 854-860.
2. Leukocyte Typing V (S.F. Schlossman, et al, eds.) Oxford University Press, Oxford, (1995) p. 840-874.
3. R.H. Collins, (1994) Stem Cells 12: 577-585.
4. T.L. Holyoake & M.J. Alcorn, (1994) Blood Reviews 8: 113-124.
5. J.P. Levesque, L.J. Bendell, et al. (2003) J Clin Invest 110: 187-196.
6. F Lanza, D.R. Sutherland, et al. (2001) 15: 1-13.
|
